1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsThis funding opportunity, part of the NIH HEAL (Helping to End Addiction Long-term) Initiative, supports the development of therapies and technologies for enhanced pain management through the Small Business Innovation Research (SBIR) program.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Eligible United States Small Business Concerns (SBCs) that propose a feasibility and/or R&D study contributing to the missions of any participating NIH, CDC, or FDA components. Confirm the full requirements in the official notice before applying.
The current listing shows varies (SBIR Phase I up to $323,090; Phase II up to $2,153,927). Verify award ceilings, matching requirements, and allowable costs in the official notice.
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed) is funded by National Institute of Neurological Disorders and Stroke (NINDS) within NIH (with participation from other NIH Institutes and Centers including NCCIH, NIAMS). Verify program details on the funder's official page before applying.
Past winners and funding trends for this program
Rejected SBIR proposal? Good — now you have reviewer feedback. Use it to address weaknesses, sharpen your aims, and resubmit stronger.
Read articleMaster the NIH resubmission process. Analyze Summary Statements, address reviewer critiques, and revise your grant proposal for funding success.
Read articleLearn winning strategies from funded NIH SBIR awardees. Practical tips on research plans, team expertise, and commercialization potential.
Read article